These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 28411673)

  • 1. Breast Cancer Risk Assessment Models and High-Risk Screening.
    Barke LD; Freivogel ME
    Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence to Support Screening Women in Their 40s.
    Ray KM; Price ER; Joe BN
    Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Breast Cancer.
    Niell BL; Freer PE; Weinfurtner RJ; Arleo EK; Drukteinis JS
    Radiol Clin North Am; 2017 Nov; 55(6):1145-1162. PubMed ID: 28991557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
    Mandelblatt JS; Stout N; Trentham-Dietz A
    Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast Cancer Screening and Optimizing Recommendations.
    Lancaster RB; Gulla S; De Los Santos J; Umphrey H
    Semin Roentgenol; 2018 Oct; 53(4):280-293. PubMed ID: 30449346
    [No Abstract]   [Full Text] [Related]  

  • 7. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
    Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
    Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
    Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer screening imaging: what do we do].
    Balu-Maestro C; Chapellier C; Souci J; Caramella T; Marcotte-Bloch C
    J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):3-10. PubMed ID: 19850418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Screening Benefits: Research and Controversies.
    Odle TG
    Radiol Technol; 2016 May; 87(5):529M-46M. PubMed ID: 27146193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Screening in the Intermediate-Risk Population: Falling Through the Cracks?
    Zaki-Metias KM; Wang H; Tawil TF; Miles EB; Deptula L; Agrawal P; Davis KM; Spalluto LB; Seely JM; Yong-Hing CJ
    Can Assoc Radiol J; 2024 Aug; 75(3):593-600. PubMed ID: 38420877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discussion of breast cancer screening model in China].
    Li WQ; Li R; Liu PF; Huang YB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1039-43. PubMed ID: 27453120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence to Support Screening Women Annually.
    Eby PR
    Radiol Clin North Am; 2017 May; 55(3):441-456. PubMed ID: 28411672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversy surrounding mammography screening? Not in our opinion.
    Drukteinis JS; Kiluk JV
    Cancer Control; 2014 Apr; 21(2):176-7. PubMed ID: 24667405
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary ACOG Practice Bulletin July 2017: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
    Mango V; Bryce Y; Morris EA; Gianotti E; Pinker K
    Br J Radiol; 2018 Oct; 91(1090):20170907. PubMed ID: 29688040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital mammography: clinical image evaluation.
    Bassett LW; Hoyt AC; Oshiro T
    Radiol Clin North Am; 2010 Sep; 48(5):903-15. PubMed ID: 20868893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of breast imaging to screen women at high risk for cancer.
    Sickles EA
    Radiol Clin North Am; 2010 Sep; 48(5):859-78. PubMed ID: 20868890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.